INIS
drugs
100%
patients
98%
populations
67%
doses
55%
data
51%
kidneys
42%
prediction
40%
modeling
35%
pediatrics
32%
validation
31%
tools
30%
clearance
30%
simulation
29%
assessments
26%
concentration
26%
medicines
25%
liver
22%
compartments
22%
plasma
21%
evaluation
20%
monitoring
20%
sampling
20%
guidelines
19%
performance
19%
risks
19%
adults
18%
absorption
18%
diseases
16%
covid-19
16%
safety
16%
values
16%
clinical trials
16%
volume
15%
applications
15%
blood
15%
weight
14%
distribution
14%
design
14%
optimization
14%
levels
13%
reviews
13%
lactams
12%
children
12%
organs
12%
antibiotics
11%
pneumonia
11%
liquid column chromatography
11%
solids
10%
transplants
9%
decision making
9%
Keyphrases
Pediatric Dose Selection
5%
Neonatal Sepsis
5%
Credibility Assessment
5%
Regulatory Evaluation
5%
Building Model
5%
Drug Model
5%
Model Credibility
5%
Pharmacometric Models
5%
Risk-informed
5%
Generic Tool
5%
Meropenem
5%
Physiologically-based Pharmacokinetic Model
5%
Infection Site
5%
Plasma Pharmacokinetics
5%
Mycophenolic Acid
5%
Pharmacokinetic Analysis
5%
Pharmacodynamic Study
5%
Expert Priors
5%
Pediatric Development
5%
Drug Formulation
5%
Bioanalytics
5%
Virtual Patient
5%
Resampling Methods
5%
Practice Papers
5%
MID3
5%
Dose Finding
5%
Industry Association
5%
Recent Experience
5%
Hydroxycholoroquine
5%
Population Pharmacokinetics
5%
In Silico Clinical Trials
5%
Early Adoption
5%
Model-informed Dosing
5%
Hydroxychloroquine
5%
Treatment Personalization
5%
Meta-analysis Approach
5%
Solid Organ Transplantation
5%
Tacrolimus
5%
Risk Prediction Model
5%
Comprehensive in Vitro Proarrhythmia Assay (CiPA)
5%
Proarrhythmia
5%
Verification & Validation
5%
In Silico Trials
5%
Biomedical Products
5%
Dose Rationale
5%
Oral Formulation
5%
Systemic Action
5%
Septic Patients
5%
Amikacin
5%
Critically Ill
5%
